Date Filed | Type | Description |
08/17/2023 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Paid exercise price by delivering 8,074 shares
@ $21.51, valued at
$173.7k
|
|
08/07/2023 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Sold 60,000 shares
@ $20.51, valued at
$1.2M
Sold 60,000 shares
@ $20.68, valued at
$1.2M
Exercised 60,000 options to buy
@ $14.74, valued at
$884.4k
Exercised 60,000 options to buy
@ $14.74, valued at
$884.4k
|
|
05/26/2023 |
4
| Senner Christopher J. (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
05/17/2023 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Paid exercise price by delivering 8,444 shares
@ $19.18, valued at
$162k
Paid exercise price by delivering 10,002 shares
@ $19.18, valued at
$191.8k
|
|
04/05/2023 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Granted 85,414 shares
@ $0 |
|
11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2022 |
4
| Senner Christopher J. (Director) has filed a Form 4 on Cortexyme, Inc.
Txns:
| Granted 27,000 options to buy
@ $3.23, valued at
$87.2k
|
|
05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2022 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Paid exercise price by delivering 2,701 shares
@ $18.59, valued at
$50.2k
Paid exercise price by delivering 15,626 shares
@ $18.59, valued at
$290.5k
|
|
12/17/2021 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Granted 19,491 shares
@ $0 Paid exercise price by delivering 5,131 shares
@ $17, valued at
$87.2k
|
|
11/17/2021 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Paid exercise price by delivering 8,227 shares
@ $18.1, valued at
$148.9k
Paid exercise price by delivering 2,566 shares
@ $18.1, valued at
$46.4k
Paid exercise price by delivering 46,920 shares
@ $18.1, valued at
$849.3k
|
|
10/04/2021 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Granted 32,567 shares
@ $0 Paid exercise price by delivering 8,573 shares
@ $20.63, valued at
$176.9k
|
|
09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Senner Christopher J. (Director) has filed a Form 4 on Cortexyme, Inc.
Txns:
| Granted 11,029 options to buy
@ $50.56, valued at
$557.6k
|
|
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2020 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Paid exercise price by delivering 2,737 shares
@ $20.16, valued at
$55.2k
Paid exercise price by delivering 8,227 shares
@ $20.16, valued at
$165.9k
Paid exercise price by delivering 2,633 shares
@ $20.16, valued at
$53.1k
|
|
10/26/2020 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Granted 178,231 shares
@ $0 Paid exercise price by delivering 46,920 shares
@ $21.79, valued at
$1M
|
|
10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/15/2020 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Sold 20,000 shares
@ $25, valued at
$500k
Exercised 20,000 options to buy
@ $3.66, valued at
$73.2k
|
|
09/04/2020 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Granted 9,745 shares
@ $0 Paid exercise price by delivering 2,566 shares
@ $21.58, valued at
$55.4k
|
|
06/09/2020 |
4
| Senner Christopher J. (Director) has filed a Form 4 on Cortexyme, Inc.
Txns:
| Granted 11,029 options to buy
@ $41.73, valued at
$460.2k
|
|
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2019 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Granted 15,592 shares
@ $0 Paid exercise price by delivering 4,090 shares
@ $17.67, valued at
$72.3k
|
|
11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/08/2019 |
3
| Senner Christopher J. (Director) has filed a Form 3 on Cortexyme, Inc. |
05/03/2019 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Sold 36,261 shares
@ $20.7, valued at
$750.6k
|
|
11/30/2018 |
4
| Senner Christopher J. (EVP and CFO) has filed a Form 4 on EXELIXIS, INC.
Txns:
| Sold 8,791 shares
@ $19.7, valued at
$173.2k
|
|
|